Reduction of synaptojanin 1 ameliorates synaptic and behavioral impairments in a mouse model of Alzheimer's disease

Journal of Neuroscience

Volumn 32, Issue 44, 2012, Pages 15271-15276

  McIntire, Laura Beth J ^a   Berman, Diego E ^a   Myaeng, Jennifer ^a   Staniszewski, Agnieszka ^a   Arancio, Ottavio ^a   Di Paolo, Gilbert ^a   Kim, Tae Wan ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN [1-40]; AMYLOID BETA PROTEIN [1-42]; BETA TUBULIN; SYNAPTOJANIN; SYNAPTOJANIN 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN SYNAPTOSOME; CELL STRUCTURE; COGNITIVE DEFECT; CONDITIONING; DENDRITIC SPINE; FEAR; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SYNAPSE; TASK PERFORMANCE; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CELLS, CULTURED; CONDITIONING (PSYCHOLOGY); CUES; DENDRITIC SPINES; FEAR; FEMALE; GENOTYPE; LIPID METABOLISM; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED STRAINS; PHOSPHATIDYLINOSITOLS; PHOSPHORIC MONOESTER HYDROLASES; PSYCHOMOTOR PERFORMANCE; SYNAPSES;

EID: 84868145167     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2034-12.2012     Document Type: Article

References (43)

1. Alamed J, Wilcock DM, Diamond DM, Gordon MN, Morgan D (2006) Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice. Nat Protoc 1:1671-1679. CrossRef Medline
2. Alldred MJ, Duff KE, Ginsberg SD (2012) Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Neurobiol Dis 45:751-762. CrossRef Medline
3. Barnes P, Good M (2005) Impaired Pavlovian cued fear conditioning in Tg2576 mice expressing a human mutant amyloid precursor protein gene. Behav Brain Res 157:107-117. CrossRef Medline
4. Benilova I, Karran E, De Strooper B (2012) The toxic A oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 15:349-357. CrossRef Medline
5. Berman DE, Dall'Armi C, Voronov SV, McIntire LB, Zhang H, Moore AZ, Staniszewski A, Arancio O, Kim TW, Di Paolo G (2008) Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism. Nat Neurosci 11:547-554. CrossRef Medline
6. Bertram L, Tanzi RE (2012) The genetics of Alzheimer's disease. Prog Mol Biol Transl Sci 107:79-100. CrossRef Medline
7. Bosch M, Hayashi Y (2012) Structural plasticity of dendritic spines. Curr Opin Neurobiol 22:383-388. CrossRef Medline
8. Calabrese B, Shaked GM, Tabarean IV, Braga J, Koo EH, Halpain S (2007) Rapid, concurrent alterations in pre-and postsynaptic structure induced by naturally-secreted amyloid-beta protein. Mol Cell Neurosci 35:183-193. CrossRef Medline
9. Chan RB, Oliveira TG, Cortes EP, Honig LS, Duff KE, Small SA, Wenk MR, Shui G, Di Paolo G (2012) Comparative lipidomic analysis of mouse and human brain with Alzheimer's disease. J Biol Chem 287:2678-2688. CrossRef Medline
10. Chiang HC, Wang L, Xie Z, Yau A, Zhong Y (2010) PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila. Proc Natl Acad Sci U S A 107:7060-7065. CrossRef Medline
11. Cossec JC, Lavaur J, Berman DE, Rivals I, Hoischen A, Stora S, Ripoll C, Mircher C, Grattau Y, Olivomarin JC, de Chaumont F, Lecourtois M, Antonarakis SE, Veltman JA, Delabar JM, Duyckaerts C, Di Paolo G, Potier MC (2012) Trisomy for Synaptojanin1 in Down syndrome is functionally linked to the enlargement 1 of early endosomes. Hum Mol Genet 21:3156-3172. CrossRef Medline
12. Cremona O, Di Paolo G, Wenk MR, Luthi A, Kim WT, Takei K, Daniell L, Nemoto Y, Shears SB, Flavell RA, McCormick DA, De Camilli P (1999) Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell 99:179-188. CrossRef Medline
13. Di Paolo G, De Camilli P (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651-657. CrossRef Medline
14. Di Paolo G, Kim TW (2011) Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat Rev Neurosci 12:284-296. CrossRef Medline
15. Gil-Bea FJ, Aisa B, Schliebs R, Ramírez MJ (2007) Increase of locomotor activity underlying the behavioral disinhibition in tg2576 mice. Behav Neurosci 121:340-344. CrossRef Medline
16. Gong LW, De Camilli P (2008) Regulation of postsynaptic AMPA responses by synaptojanin 1. Proc Natl Acad Sci U S A 105:17561-17566. CrossRef Medline
17. Haffner C, Takei K, Chen H, Ringstad N, Hudson A, Butler MH, Salcini AE, Di Fiore PP, De Camilli P (1997) Synaptojanin 1: localization on coated endocytic intermediates in nerve terminals and interaction of its 170 kDa isoform with Eps15. FEBS Lett 419:175-180. CrossRef Medline
18. Haugabook SJ, Le T, Yager D, Zenk B, Healy BM, Eckman EA, Prada C, Younkin L, Murphy P, Pinnix I, Onstead L, Sambamurti K, Golde TE, Dickson D, Younkin SG, Eckman CB (2001) Reduction of A accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidylinositol kinase inhibitor wortmannin. FASEB J 15:16-18. CrossRef Medline
19. Hernandez CM, Kayed R, Zheng H, Sweatt JD, Dineley KT (2010) Loss of 7 nicotinic receptors enhances-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease. J Neurosci 30:2442-2453. CrossRef Medline
20. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102. CrossRef Medline
21. Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148:1204-1222. CrossRef Medline
22. Kopec CD, Li B, Wei W, Boehm J, Malinow R (2006) Glutamate receptor exocytosis and spine enlargement during chemically induced long-term potentiation. J Neurosci 26:2000-2009. CrossRef Medline
23. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) A oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807. CrossRef Medline
24. Landman N, Jeong SY, Shin SY, Voronov SV, Serban G, Kang MS, Park MK, Di Paolo G, Chung S, Kim TW (2006) Presenilin mutations linked to familial Alzheimer's disease cause an imbalance in phosphatidylinositol 4,5-bisphosphate metabolism. Proc Natl Acad Sci U S A 103:19524-19529. CrossRef Medline
25. Lee SY, Wenk MR, Kim Y, Nairn AC, De Camilli P (2004) Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses. Proc Natl Acad Sci U S A 101:546-551. CrossRef Medline
26. Mandal M, Yan Z (2009) Phosphatidylinositol (4,5)-bisphosphate regulation of N-methyl-D-aspartate receptor channels in cortical neurons. Mol Pharmacol 76:1349-1359. CrossRef Medline
27. Maren S (2008) Pavlovian fear conditioning as a behavioral assay for hippocampus and amygdala function: cautions and caveats. Eur J Neurosci 28:1661-1666. CrossRef Medline
28. McCrea HJ, De Camilli P (2009) Mutations in phosphoinositide metabolizing enzymes and human disease. Physiology (Bethesda) 24:8-16. CrossRef Medline
29. Michailidis IE, Helton TD, Petrou VI, Mirshahi T, Ehlers MD, Logothetis DE (2007) Phosphatidylinositol-4,5-bisphosphate regulates NMDA receptor activity through-actinin. J Neurosci 27:5523-5532. CrossRef Medline
30. Miller JA, Oldham MC, Geschwind DH (2008) A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J Neurosci 28:1410-1420. CrossRef Medline
31. Oliveira TG, Chan RB, Tian H, Laredo M, Shui G, Staniszewski A, Zhang H, Wang L, Kim TW, Duff KE, Wenk MR, Arancio O, Di Paolo G (2010) Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits. J Neurosci 30:16419-16428. CrossRef Medline
32. Osawa S, Funamoto S, Nobuhara M, Wada-Kakuda S, Shimojo M, Yagishita S, Ihara Y (2008) Phosphoinositides suppress gamma-secretase in both the detergent-soluble and-insoluble states. J Biol Chem 283:19283-19292. CrossRef Medline
33. Osenkowski P, Ye W, Wang R, Wolfe MS, Selkoe DJ (2008) Direct and potent regulation of gamma-secretase by its lipid microenvironment. J Biol Chem 283:22529-22540. CrossRef Medline
34. Petanceska SS, Gandy S (1999) The phosphatidylinositol 3-kinase inhibitor wortmannin alters the metabolism of the Alzheimer's amyloid precursor protein. J Neurochem 73:2316-2320. CrossRef Medline
35. Pozueta J, Lefort R, Shelanski ML (2012) Synaptic changes in Alzheimer's disease and its models. Neuroscience. Advance online publication. Retrieved September 15, 2012. doi:10.1016/j.neuroscience.2012.05.050. CrossRef Medline
36. Rodriguez A, Ehlenberger DB, Dickstein DL, Hof PR, Wearne SL (2008) Automated three-dimensional detection and shape classification of dendritic spines from fluorescence microscopy images. PLoS One 3:e1997. CrossRef Medline
37. Sanchez-Mejia RO, Mucke L (2010) Phospholipase A2 and arachidonic acid in Alzheimer's disease. Biochim Biophys Acta 1801:784-790. CrossRef Medline
38. Schmidt SD, Jiang Y, Nixon RA, Mathews PM (2005) Tissue processing prior to protein analysis and amyloid-beta quantitation. Methods Mol Biol 299:267-278. Medline
39. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloidprotein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866-2875. CrossRef Medline
40. Smith DL, Pozueta J, Gong B, Arancio O, Shelanski M (2009) Reversal of long-term dendritic spine alterations in Alzheimer disease models. Proc Natl Acad Sci U S A 106:16877-16882. CrossRef Medline
41. Treusch S, Hamamichi S, Goodman JL, Matlack KE, Chung CY, Baru V, Shulman JM, Parrado A, Bevis BJ, Valastyan JS, Han H, Lindhagen-Persson M, Reiman EM, Evans DA, Bennett DA, Olofsson A, DeJager PL, Tanzi RE, Caldwell KA, Caldwell GA, et al (2011) Functional links between A toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science 334:1241-1245. CrossRef Medline
42. Voronov SV, Frere SG, Giovedi S, Pollina EA, Borel C, Zhang H, Schmidt C, Akeson EC, Wenk MR, Cimasoni L, Arancio O, Davisson MT, Antonarakis SE, Gardiner K, De Camilli P, Di Paolo G (2008) Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome. Proc Natl Acad Sci U S A 105:9415-9420. CrossRef Medline
43. Wu K, Sachs L, Carlin RK, Siekevitz P (1986) Characteristics of a Ca2 / calmodulin-dependent binding of the Ca2 channel antagonist, nitrendipine, to a postsynaptic density fraction isolated from canine cerebral cortex. Brain Res 387:167-184. Medline